{
      "brief_title": [
            "safety",
            "efficacy",
            "natalizumab",
            "combination",
            "avonex",
            "treatment",
            "multiple",
            "sclerosis"
      ],
      "brief_summary": [
            "purpose",
            "study",
            "determine",
            "natalizumab",
            "combination",
            "avonex",
            "safe",
            "effective",
            "delay",
            "progression",
            "individual",
            "diagnose",
            "relapse",
            "remit",
            "multiple",
            "sclerosis",
            "m"
      ],
      "condition": [
            "multiple",
            "sclerosis"
      ],
      "intervention_type": [
            "drug"
      ],
      "intervention_name": [
            "placebo"
      ],
      "description": [
            "placebo",
            "monthly",
            "infusion",
            "116",
            "week"
      ],
      "arm_group_label": [
            "group",
            "2"
      ],
      "other_name": [
            "tysabri"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "diagnosis",
            "m",
            "define",
            "mcdonald",
            "et",
            "al",
            "criterion",
            "4",
            "age",
            "18",
            "55",
            "inclusive",
            "baseline",
            "eds",
            "score",
            "inclusive",
            "treat",
            "avonex",
            "least",
            "12",
            "month",
            "prior",
            "randomization",
            "experience",
            "least",
            "one",
            "relapse",
            "avonex",
            "within",
            "12",
            "month",
            "prior",
            "randomization",
            "cranial",
            "mri",
            "scan",
            "demonstrate",
            "lesion",
            "consistent",
            "give",
            "write",
            "inform",
            "consent",
            "participate",
            "study",
            "exclusion",
            "criterion",
            "primary",
            "progressive",
            "secondary",
            "progressive",
            "progressive",
            "relapse",
            "m",
            "relapse",
            "occur",
            "within",
            "50",
            "day",
            "randomization",
            "clinically",
            "significant",
            "infectious",
            "illness",
            "within",
            "30",
            "day",
            "prior",
            "randomization",
            "history",
            "abnormal",
            "lab",
            "result",
            "indicative",
            "significant",
            "disease",
            "opinion",
            "investigator",
            "would",
            "preclude",
            "administration",
            "recombinant",
            "humanize",
            "antibody",
            "immunomodulating",
            "agent",
            "avonex",
            "116",
            "week",
            "history",
            "severe",
            "allergic",
            "anaphylactic",
            "reaction",
            "know",
            "drug",
            "hypersensitivity",
            "unable",
            "perform",
            "time",
            "walk",
            "pasat",
            "3",
            "abnormal",
            "blood",
            "test",
            "screen",
            "visit"
      ],
      "gender": [],
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [
            "55",
            "year"
      ],
      "healthy_volunteers": false,
      "id": "NCT00030966.xml"
}